Biochemical and biophysical research communicationsHumansInsulin ResistanceGlucagon-Like Peptide-1 Receptor AgonistsInflammationAnimals
GLP-1 receptor agonists and inflammatory pathway modulation: Dual targeting of metabolic and immune dysfunction in insulin resistance.
Murtala A Ngabea, Igbayilola Yusuff Dimeji
Published: 202510.1016/j.bbrc.2025.152822
Abstract
Because of their extensive effects on glycaemic management and weight loss, glucagon-like peptide-1 receptor agonists (GLP-1RAs) are showing promise as therapeutic agents in the treatment of type 2 diabetes mellitus (T2DM) and obesity. Their therapeu…
Preview only. Read the full abstract at the source